Affecting 2% of hospitalized patients, severe cutaneous adverse reactions (SCARs) are associated with high health care cost, morbidity, and mortality.1 SCARs are a class of life-threatening reactions that typically include Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS) or drug hypersensitivity induced syndrome, and acute generalized exanthematous pustulosis (AGEP).2
http://ift.tt/2khNP2C
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου